prazosin has been researched along with Hyperphagia in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Hyperphagia: Ingestion of a greater than optimal quantity of food.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janhunen, SK | 1 |
van der Zwaal, EM | 1 |
la Fleur, SE | 1 |
Adan, RA | 1 |
Mansur, SS | 1 |
Terenzi, MG | 1 |
Marino Neto, J | 1 |
Faria, MS | 1 |
Paschoalini, MA | 1 |
2 other studies available for prazosin and Hyperphagia
Article | Year |
---|---|
Inverse agonism at α2A adrenoceptors augments the hypophagic effect of sibutramine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Cyclobutanes | 2011 |
Alpha1 receptor antagonist in the median raphe nucleus evoked hyperphagia in free-feeding rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Eating; F | 2011 |